+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 45Years
FEMALE
ID07779057

Effects of High Versus Low Dose Aspirin on Pregnancy Outcomes in Women at High Risk of Preeclampsia

Led by Medicare Hospital (Pvt) Limited · Updated on 2026-08-21

60

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of two different aspirin doses, 75 mg and 150 mg, in pregnant women who are at high risk of developing preeclampsia. The main goals are to see if the higher dose reduces preeclampsia more effectively and to compare stillbirth rates and newborn birth weights between the two doses. This is a randomized clinical trial involving 224 pregnant women aged 18 to 45 years, who are between 11 and 14 weeks of pregnancy. Participants will be randomly assigned to take either 75 mg or 150 mg of aspirin orally once daily at bedtime, starting from 11 to 14 weeks of pregnancy until 36 weeks. The study uses a parallel design with two groups receiving different aspirin doses. Follow-up visits will occur every two weeks until delivery to monitor progress. During the study, participants will be regularly evaluated for the development of preeclampsia and occurrence of stillbirth. Newborn birth weight will be measured within three hours after birth. The primary outcome is the incidence of preeclampsia from enrollment until delivery. Secondary outcomes include stillbirth rates. Participants will be followed up until delivery, with assessments every two weeks.

CONDITIONS

Brief Title

Comparison of High- Versus Low-Dose Aspirin for Pregnancy Outcomes in Women at High Risk of Preeclampsia

Research Team

F

Fiza A Principal Investigator, MBBS

S

Samee A Professor, FRCOG

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here